CME and CFTC Clash Over On-Chain Perpetual Futures

The US derivatives market is witnessing an unusual showdown between the CME Group, the largest derivatives exchange operator, and its regulator, the Commodity Futures Trading Commission (CFTC), over the introduction of blockchain-based perpetual futures products. The controversy began when the CFTC approved the listing of crypto perpetual futures, also known as perps, on the prediction markets platform Kalshi and cryptocurrency exchange Coinbase, despite the CME's objections. The CME has sued the CFTC, arguing that the products are harmful to its traditional futures contracts and that the regulator has mislabeled them, thereby misapplying the law. The dispute has significant implications for the rapidly growing US crypto derivatives market, with non-US perps volume reportedly reaching $60 trillion in volume last year. The CME claims that perps, which allow users to speculate on the price of an asset with leverage and no expiration date, are swaps and should be subject to stricter regulations. The CFTC, on the other hand, has taken a more permissive approach, allowing registered companies, including the CME, to offer these products. The regulator's decision has been met with frustration from some quarters, with critics arguing that the CME is trying to stifle innovation and maintain its dominance in the market. The lawsuit has sparked a heated debate about the regulation of crypto derivatives in the US, with some arguing that the CFTC's approach is too lenient and others claiming that the CME is trying to use regulation to block competition. The outcome of the dispute is likely to have far-reaching consequences for the US crypto market and the development of on-chain derivatives products.